Covington & Burling advised Lantheus Holdings, Inc. on the deal. Lantheus Holdings, Inc. (Nasdaq: LNTH) (Lantheus) announced its definitive agreement to acquire Life Molecular Imaging Limited,...
Lantheus’ $750 Million Acquisition of Life Molecular Imaging
Getinge’s $477 Million Acquisition of Paragonix Technologies
Covington & Burling represented Getinge in the transaction. Getinge announced its acquisition of Paragonix Technologies, Inc., a leading organ transport products and services company in the...
Selecta Biosciences’ Merger with Cartesian Therapeutics
Covington & Burling advised Selecta Biosciences, Inc. on the transaction, and Foley Hoag advised Cartesian Therapeutics. Selecta Biosciences (Nasdaq:SELB) (“Selecta”) announced its merger with Cartesian Therapeutics and concurrent...
NewAmsterdam Pharma’s DeSPAC Merger with Frazier Lifesciences
Covington and NautaDutilh advised NewAmsterdam Pharma on the deal, while Latham & Watkins advised Lincoln International. Houthoff assisted Frazier Lifesciences Acquisition Corp. NewAmsterdam Pharma Holding B.V.,...